Charles Botbol
- Full Name:
- Charles Isaac Botbol
- Registration Number:
- 13209
- Current Status:
- Member
- Designated Electoral District:
- District 12
Concerns, Conditions and/or Professional Misconduct
Practice Information
Primary Practice
Dr. Charles Botbol and Associates
- Sedation & Anesthesia Facility Permit:
- Yes
- CT Scanner Facility Permit:
- No
See Hide All Practice Locations
All Practice Locations
-
Dr. Charles Botbol and Associates
- Sedation & Anesthesia Facility Permit:
- Yes
- CT Scanner Facility Permit:
- No
See Hide Professional Corporation Information
Professional Corporation Information
-
Dr. Charles Botbol Dentistry Professional Corporation
2-27 Rean Dr
Toronto, ON, CA
M2K 0A6
Phone: 416-226-2000
- Certificate of Authorization Status:
- Current
- Certificate of Authorization Issuance:
- November 08, 2023
-
Dr. Charles Botbol Dentistry Professional Corporation
27 Rean Dr #2
Toronto, ON, CA
M2K 0A6
Phone: 416-226-2000
- Certificate of Authorization Status:
- Revoked - Corporation Not Renewed
- Date of revocation:
- September 01, 2023
- Certificate of Authorization Issuance:
- April 12, 2017
Academic Information
Dental Degree
- 1996
- University of Toronto, Canada
This may not be a complete record of the member's academic information or continuing education.
Certificate(s) of Registration
Current Certificate(s) of Registration and Date(s) of Issuance
- General
Initial Date of Registration
Sedation & Anesthesia Details
Sedation Administration Authorization
Minimal Nitrous Oxide/Oral SedationLast Inspection Date for Dentist
June 17, 2021
See All Associated Sedation & Anesthesia Facilities
-
- Address:
- 27 Rean Dr #2 Toronto, ON, CA M2K 0A6
- Phone #:
- 416-226-2000
- Permit Status:
- Current
- Permit Type:
- Type B
- Facility Modality:
- Deep Sedation/General Anesthesia
Complaints & Reports Outcomes
Case File: 21-0400
- Decision Date:
- January 03, 2023
Caution
- Current Status:
- Completed
-
As a result of a complaint, the Inquiries, Complaints and Reports Committee decided to caution Dr. Charles Botbol as follows: • You did not appropriately evaluate and communicate the likelihood of implant success. The Canaray report showed the implant sites had a high risk of failure so it was inadvisable for you to proceed with the “All on 4” treatment. • You did not thoroughly discuss and document treatment options and risks, including the specific risks to the patient, before proceeding with treatment. Remember that informed consent is a process of communication and not a signed form in the absence of meaningful dialogue. • You should always tell patients that immediate implant placement is likely to be less successful than waiting for the surgical site to heal, particularly if you are grafting bone. This discussion must be documented and the patient should be given the option of waiting for implant placement and loading. • You should consider referral to a specialist when a case is challenging and offer this option to the patient.